Evidence map›Paper›PMID 38058800›Full record

ArticleAmerican journal of cancer research2023

MIR-376A-2-5P as a potential prognostic marker for advanced penile squamous cell carcinomas trough HPV-dependent pathways.

Jenilson M Silva, Amanda J Deus, André A M Vale, Ana Paula S Azevedo-Santos, Leudivan Nogueira, Ana C Laus, Luciane Sussuchi, Rui M Reis, Alexander Birbrair, André S Khayat and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Jenilson M SilvaPostgraduate Program in Health Science, Federal University of Maranhão São Luís 65080-805, MA, Brazil.
Amanda J DeusPostgraduate Program in Health Science, Federal University of Maranhão São Luís 65080-805, MA, Brazil.
André A M ValeLaboratory of Genetics and Molecular Biology, Department of Biology, Federal University of Maranhão São Luís 65080-805, MA, Brazil.
Ana Paula S Azevedo-SantosLaboratory of Applied Cancer Immunology, Department of Physiological Sciences, Federal University of Maranhão São Luís 65080-805, MA, Brazil.
Leudivan NogueiraAldenora Bello Cancer Hospital São Luís 65031-630, MA, Brazil.
Ana C LausMolecular Oncology Research Center, Barretos Cancer Hospital Barretos 14784-400, SP, Brazil.
Luciane SussuchiMolecular Oncology Research Center, Barretos Cancer Hospital Barretos 14784-400, SP, Brazil.
Rui M ReisMolecular Oncology Research Center, Barretos Cancer Hospital Barretos 14784-400, SP, Brazil.
Alexander BirbrairDepartment of Pathology, Federal University of Minas Gerais Belo Horizonte 31270-901, MG, Brazil.
André S KhayatOncology Research Center, Federal University of Pará Belém 66073-005, PA, Brazil.
Silma Regina PereiraLaboratory of Genetics and Molecular Biology, Department of Biology, Federal University of Maranhão São Luís 65080-805, MA, Brazil.
Universidade Federal do Maranhão · BRHospital de Câncer de Barretos · BRHospital São Paulo · BRInstituto Federal de Educação, Ciência e Tecnologia do Pará · BRUniversidade Federal de Minas Gerais · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Penile cancer (PeCa) is a rare tumor, generally associated with socioeconomic conditions in low-income countries. Hence, a delay in diagnosis and treatment leads in more advanced tumors, to higher comorbidity, and mortality. Human papillomavirus (HPV) infection has been identified as one of the major risk factors for PeCa. In addition, viral integration sites have been related to copy number alterations, impacting miRNAs/mRNA interactions and, consequently, the molecular pathways related to them. Nonetheless, studies on differentially expressed miRNAs (miRDEs) in PeCa are still scarce, especially in PeCa associated with high-risk HPV (hrHPV). To investigate the role of these gene regulators in PeCa progression, 827 miRNAs (Nanostring Technologies™, Seattle, WA, USA) were evaluated in 22 hrHPV-associated penile squamous cell carcinomas and five non-tumor penile tissues. For functions of miRNAs/target genes and relationship with HPV we conducted an integrated analysis by Diana Tools, KEGG, HPVbase, and InterSPPI-HVPPI platforms. We found that 25 miRNAs of the most differentially expressed impact 43 top molecular pathways, of which the fatty acid biosynthesis pathway, prions, miRNAs in cancer and hippo signaling (P<1.0

Indexed as

HPV-integration sitesmiRNAspenile cancerperineural invasionprognostic markers

Identifiers

PMID38058800
PMCPMC10695795
OpenAlexW4389453053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.